Chiara Casale

Chiara Casale

Auto-generated profile, based on publicly available information

Chiara Casale

Radiation Oncology Unit, A.O.U. Città della Salute e della Scienza, Torino, Italy

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 April 2026 in Radiotherapy and Oncology
Verified
Journal Article
Open access
MLMario Levis
Mario Levis
PSPaolo Solidoro
Paolo Solidoro
FGFrancesca Romana Giglioli
Francesca Romana Giglioli
EGElena Gallio
Elena Gallio
CCChiara Casale
Chiara Casale
URUmberto Ricardi
Umberto Ricardi
This study explored Continuous Positive Airway Pressure (CPAP) as an alternative to breath-holding (DIBH) techniques by comparing it with free-breathing (FB) in mediastinal lymphoma patients treated with optimized volumetric arc therapy (VMAT). Patients underwent computed tomography (CT) simulation in both FB and CPAP (18 cm H2O). The amount of residual respiratory motion with CPAP was assessed using 4D-CT in 27 patients. Lungs, breasts, heart, and cardiac structures were contoured and included in VMAT optimization. Maximum and mean doses were compared for all organs, and CPAP was used if beneficial. Risks of coronary artery disease (CAD) and chronic heart failure (CHF) were estimated via excess relative risk (ERR). The study included 58 patients (22 males, 36 females; mean age 29 years) with Hodgkin (45) or large B-cell lymphoma (13). The median prescribed dose was 30 Gy (range 30-40 Gy). CPAP was well tolerated by all patients. Only nine patients (16%) had no dosimetric benefit from CPAP and were treated in FB. CPAP increased mean lung volume by 1.6 L (4460 vs 2810 cc, p < 0.01) minimized respiratory motion in patients assessed with 4D-CT (mean residual excursion: 388 cc), and significantly reduced lung V20 (10% vs 12.7%, p < 0.01) and V5 (38.2% vs 42.7%, p < 0.01). Moreover, CPAP decreased the intersection of the whole heart with planning target volume (27.9 to 20.9 cc, p < 0.01), which resulted in lower mean doses to the heart (5.3 vs 6.1 Gy, p < 0.01), coronary arteries (7.6 vs 9.5 Gy, p < 0.01), and left ventricle (2.8 vs 3.5 Gy, p < 0.01). CAD and CHF risks significantly reduced with CPAP (p < 0.01). CPAP significantly reduced radiation doses to lungs and heart, was well tolerated and easy to implement and to use also in department with high patients workload, representing a valid and reproducible alternative to DIBH in mediastinal lymphoma radiotherapy.